# Hyaluronic Acid-Based Gels and Biomaterial Systems for Oral Wound Healing: Design and Clinical Translation

**Authors:** Vlad Constantin, Ionut Luchian, Dragos Ioan Virvescu, Mihaela Scurtu, Nicoleta Tofan, Dan Nicolae Bosinceanu, Elena Raluca Baciu, Carina Balcos, Monica Mihaela Scutariu, Dana Gabriela Budala

PMC · DOI: 10.3390/gels12030262 · Gels · 2026-03-22

## TL;DR

This paper reviews how hyaluronic acid gels may help heal oral wounds, but more standardized research is needed to confirm their effectiveness.

## Contribution

The paper systematically reviews clinical evidence and identifies gaps in standardization for hyaluronic acid use in oral wound healing.

## Key findings

- HA may reduce postoperative discomfort and accelerate healing in oral mucosal wounds.
- Current studies show variability in HA formulations and application protocols.
- More clinical trials are needed to determine optimal HA formulations for oral healing.

## Abstract

Hyaluronic acid (HA), a naturally occurring glycosaminoglycan and major component of the extracellular matrix, has attracted increasing interest as a therapeutic adjunct in oral wound management due to its biological activity and biocompatibility. The search for the current narrative review literature was performed in the PubMed/MEDLINE, Scopus, and Web of Science databases for studies published up to December 2025. Eligible studies included experimental investigations, clinical trials, and relevant reviews assessing HA applications in oral mucosal or gingival wounds. Available clinical evidence suggests potential benefits of HA in reducing postoperative discomfort, accelerating re-epithelialization, and improving soft tissue healing following periodontal and surgical procedures. However, substantial heterogeneity exists regarding molecular weight, formulation, concentration, and application protocols, which limits direct comparison between studies and precludes definitive conclusions. Further well-designed, standardized clinical trials are required to clarify optimal formulations and confirm long-term therapeutic benefits.

## Full-text entities

- **Genes:** TLR2 (toll like receptor 2) [NCBI Gene 7097] {aka CD282, TIL4}, HMMR (hyaluronan mediated motility receptor) [NCBI Gene 3161] {aka CD168, IHABP, RHAMM}, TLR4 (toll like receptor 4) [NCBI Gene 7099] {aka ARMD10, CD284, TLR-4, TOLL}, CD44 (CD44 molecule (IN blood group)) [NCBI Gene 960] {aka CDW44, CSPG8, ECM-III, ECMR-III, H-CAM, HCELL}
- **Diseases:** diabetes (MESH:D003920), postoperative pain (MESH:D010149), inflammatory drugs (MESH:D000081015), pain (MESH:D010146), cytotoxicity (MESH:D064420), immunological dysregulation (MESH:D007154), malnutrition (MESH:D044342), diseases (MESH:D004194), infection (MESH:D007239), mucosal ulcers (MESH:D014456), injuries to (MESH:D014947), lesions (MESH:D009059), inflammation (MESH:D007249), edema (MESH:D004487), oral mucosa injury (MESH:C565008), periodontal defects (MESH:D010518), fibrosis (MESH:D005355), tissue injury (MESH:D017695), autoimmune illnesses (MESH:D001327), metabolic disorders (MESH:D008659)
- **Chemicals:** disaccharide (MESH:D004187), HA (MESH:D006820), DVS (MESH:D000069468), chitosan (MESH:D048271), oxygen (MESH:D010100), sulfate (MESH:D013431), polymer (MESH:D011108), D-glucuronic acid (MESH:D020723), hyaluronic acid polysaccharide (-), 1,4-butanediol diglycidyl ether (MESH:C014376), calcium (MESH:D002118), hydrogen (MESH:D006859), carbodiimide (MESH:D002234), water (MESH:D014867), N-acetyl-D-glucosamine (MESH:D000117), glycosaminoglycan (MESH:D006025), divinyl sulfone (MESH:C009873), phosphate (MESH:D010710), sodium (MESH:D012964)
- **Species:** Homo sapiens (human, species) [taxon 9606], Hepatovirus A (no rank) [taxon 12092]
- **Cell lines:** HA — Homo sapiens (Human), Neuroblastoma, Cancer cell line (CVCL_D044)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13026109/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13026109/full.md

## References

105 references — full list in the complete paper: https://tomesphere.com/paper/PMC13026109/full.md

---
Source: https://tomesphere.com/paper/PMC13026109